《表1 4 EGFR-TKI相关性甲沟炎的治疗Tab 14 Treatment of paronychia in patients treated with EGFR-TKI》
提示：宽带有限、当前游客访问压缩模式
针对痤疮样皮疹和甲沟炎的具体治疗方法见表13和表14。
| 图表编号 | XD0030746800 严禁用于非法目的 |
|---|---|
| 绘制时间 | 2019.02.20 |
| 作者 | 胡洁、林丽珠、骆肖群、茅益民、周建英、张燕群 |
| 绘制单位 | 北京大学肿瘤医院口腔科 |
| 更多格式 | 高清、无水印（增值服务） |
![表5 EGFR-TKI相关性腹泻的处理措施[24]Tab 5 Management of diarrhoea in patients treated with EGFR-TKI[24]](http://bookimg.mtoou.info/tubiao/gif/FAIZ201902001_49100.gif)
相关图表
- 《表1 136例患者 (138个瘤体) 不同内镜治疗方式的效果Tab 1 Effect of different endoscopic treatment methods in 136 patients (138 tumors)》2019.02.20
- 《表1 两组患者治疗效果对比 (n=70, 例/%) Tab 1 Comparison of treatment effects in two groups of patients (n=70, cases/%)》2019.01.08
- 《表1《金匮要略》中大枣组方治疗疾病的分类Tab.1 Classification in the treatment of diseases of jujube formula of Jinguiyaolue》2019.04.28
- 《表1 3 EGFR-TKI相关性痤疮样皮疹的治疗Tab 13 Treatment of acne-like rash in patients treated with EGFR-TKI》2019.02.20
- 《表1 5 不同EGFR-TKI的相关III期临床研究中口腔粘膜炎的发生率Tab 15 Incidence of stomatitis/mucositis in phase III clinical trials about differen》2019.02.20
- 《表1 2 EGFR-TKI相关性痤疮样皮疹和甲沟炎的预防措施Tab 12 Prevention measures of acne-like rash and paronychia in patients treated with EGFR-》2019.02.20
- 《表3 不同EGFR-TKI的相关III期临床研究中腹泻发生率Tab 3 Incidence of diarrhoea in phase III clinical trials about different EGFR-TKI》2019.02.20
- 《表1 7 EGFR-TKI相关性口腔粘膜炎危险因素及危害Tab 17 Risk factors and harm of stomatitis/mucositis in patients taking EGFR-TKI》2019.02.20
- 《表1 8 EGFR-TKI相关性口腔粘膜炎管理措施Tab 18 Management of stomatitis/mucositis in patients treated with EGFR-TKI》2019.02.20
- 《表5 EGFR-TKI相关性腹泻的处理措施[24]Tab 5 Management of diarrhoea in patients treated with EGFR-TKI[24]》2019.02.20
- 《表1 9 不同EGFR-TKI的相关III期临床研究中ILD的发生率和死亡率Tab 19 Incidence of ILD in phase III clinical trials》2019.02.20
- 《表2 0 不同EGFR-TKI相关性ILD发生时间Tab 20 Time of ILD in patients treated with EGFR-TKI》2019.02.20
- 《表1 1 痤疮样皮疹和甲沟炎的分级标准Tab 11 Grades criteria for acne-like rash and paronychia》2019.02.20
- 《表4 两组治疗前后心理评分对比 (±s, 分) Tab.4 Comparison of psychological scores before and after treatment in two groups (±s, points)》2018.03.01
- 《表1 两组治疗优良率分析[n (%) ]Tab.1 Analysis of treatment and good rate in both groups[n (%) ]》2018.03.01
- 《表2 应用PVP治疗脊柱转移瘤的科室Tab.2 Application of PVP in the treatment of spinal metastases》2018.05.19
- 《表4 治疗组治疗前后相关指数比较 (±s) Table 4 Comparision of relevant indexes before and after treatment in the treatment group (±s)》2018.02.20
- 《表1 4 球幕组反应时间配对样本相关性Tab.14 Paired-samples correlation of reaction time in the fulldome group》2018.08.20
- 《表1 治疗前后2组患者的检测指标Tab.1 Parameters of patients in two groups before and after treatment》2018.11.28
- 《表2 2组患儿治疗总有效率Tab.2 Total effective rates of treatment of patients in two groups》2018.01.28